CLINICAL_TRIALS ClinicalTrials.gov record update

Hypofractionated 5x5 Gy Radiotherapy With Sequential Doxorubicin and Ifosfamide-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03651375
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:51.028897+00:00
Published At: 2021-01-22T00:00:00+00:00
Record Updated At: 2021-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sarcoma", "Fibrosarcoma", "Leiomyosarcoma", "Liposarcoma", "Myosarcoma", "Histiocytic Sarcoma", "Synovial Sarcoma", "Lymphangiosarcoma", "Malignant Peripheral Nerve Sheath Tumors", "Myxofibrosarcoma", "Myxoid Liposarcoma", "Undifferentiated Sarcoma", "Pleomorphic Liposarcoma", "Undifferentiated Pleomorphic Sarcoma", "Dedifferentiated Liposarcoma", "Pleomorphic Rhabdomyosarcoma", "Malignant Triton Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-01-22"
protocolSection.identificationModule.nctId: "NCT03651375"
protocolSection.identificationModule.officialTitle: "Hypofractionated 5x5 Gy Radiotherapy With Sequential Doxorubicin and Ifosfamide-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.